75% of newly emerging infectious diseases over last three decades are zoonotic in nature: Union Health Secretary
Pant delivers keynote address at National Conclave on “Augmented Zoonotic Diseases Surveillance at Human – Wildlife Interface”
Pant delivers keynote address at National Conclave on “Augmented Zoonotic Diseases Surveillance at Human – Wildlife Interface”
New effective carrier systems for drug delivery in different dosage applications including oral, topical & parenteral
NexCAR19 is an indigenously developed CD19 targeted CAR-T cell therapy
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
The product is an additional formulation of Cresemba Capsule 100 mg and Cresemba Intravenous Infusion 200 mg
Aim is to treat Dyslipidemia by inhibiting PCSK9 with a novel entity
The introduction of 'Definisse Core Filler' is a testament to the company's premium scientific-based innovation
Capital raise to accelerate product and technology development and support expansion efforts to reshape communications to HCPs across the globe
Subscribe To Our Newsletter & Stay Updated